Increase/Decrease in Cash: The total change in cash for the company over the given period.
Galderma Group AG - Unsponsored ADR (GALDY) had Increase/Decrease in Cash of $323.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.44B |
|
$1.07B |
|
$11.28B |
|
$13.39B |
|
$2.06B |
|
$2.69B |
|
$3.19B |
|
$5.24B |
|
$8.15B |
|
$-1.62B |
|
$8.15B |
|
-- |
|
| Cash Flow Statement Financials | |
$1.19B |
|
$-154.00M |
|
$-728.00M |
|
$457.00M |
|
$780.00M |
|
|
Increase/Decrease in Cash |
$323.00M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|